An Extension Study of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis

Clinical trial NCT02531126 · COMPLETED

Trial details

NCT number: NCT02531126
Sponsor: Celgene
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Ulcerative Colitis

Start date: 2015-12-02
Primary completion: 2024-12-19
Enrollment: 877

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.